We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZETA:NYSEZeta Global Holdings Corp. Analysis

Data as of 2026-09-23 - not real-time

$30.54

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $30.54, Zeta Global Holdings Corp. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 10.9%. Relative strength is 55.7 — neutral — and the MACD signal is bearish. The recent range runs from support at $27.20 up to resistance at $32.81.
On valuation the read is fair — earnings multiple of 25.3 versus a 34.6 sector average, below the peer group. Revenue is growing at 43.5% on a -0.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 47.8%, a beta of 2.25 and a maximum drawdown of 40.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Zeta Global Holdings Corp ZETA delivers 20th consecutive beat-and-raise quarter, driven by strong AI adoption and...Zeta Global Holdings Corp ZETA delivers 20th consecutive beat-and-raise quarter, driven by strong AI adoption and...Why Zeta Global Holdings Stock Is Back in Focus After Its Latest Earnings Zeta Global Holdings ZETA is drawing fresh...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 20.81
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 25.3 versus sector average of 34.6
  • Trading above the 200-day average of 20.81

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 25.3 versus sector average of 34.6
  • Negative profit margin of -0.1%
  • Negative return on equity of -0.3%

Key Metrics & Analysis

Financial Health

Revenue Growth43.50%
Profit Margin-0.14%
P/E Ratio25.3
ROE-0.27%
ROA2.60%
Debt/Equity23.77
P/B Ratio8.3
Op. Cash Flow$241.0M
Free Cash Flow$252.2M
Industry P/E34.6

Technical Analysis

TrendBullish
RSI55.7
Support$27.20
Resistance$32.81
MA 20$30.55
MA 50$26.98
MA 200$20.81
MACDBearish
VolumeDecreasing
Fear & Greed Index96.04

Valuation

Fair Value$34.30
Target Price$31.36
Upside/Downside2.68%
GradeFair
TypeGrowth

Risk Assessment

Beta2.25
Volatility47.76%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.